Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSI) Cash from Investing Activities (2022 - 2025)

Historic Cash from Investing Activities for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to -$176000.0.

  • TriSalus Life Sciences' Cash from Investing Activities fell 414.2% to -$176000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$847000.0, marking a year-over-year decrease of 2698.65%. This contributed to the annual value of -$345000.0 for FY2024, which is 7827.46% up from last year.
  • According to the latest figures from Q3 2025, TriSalus Life Sciences' Cash from Investing Activities is -$176000.0, which was down 414.2% from $93000.0 recorded in Q2 2025.
  • In the past 5 years, TriSalus Life Sciences' Cash from Investing Activities ranged from a high of $93000.0 in Q2 2025 and a low of -$1.6 million during Q3 2022
  • In the last 4 years, TriSalus Life Sciences' Cash from Investing Activities had a median value of -$74000.0 in 2023 and averaged -$301066.7.
  • Examining YoY changes over the last 5 years, TriSalus Life Sciences' Cash from Investing Activities showed a top increase of 25500.0% in 2025 and a maximum decrease of 98181.82% in 2025.
  • Quarter analysis of 4 years shows TriSalus Life Sciences' Cash from Investing Activities stood at -$272000.0 in 2022, then crashed by 36.76% to -$372000.0 in 2023, then skyrocketed by 86.56% to -$50000.0 in 2024, then plummeted by 252.0% to -$176000.0 in 2025.
  • Its last three reported values are -$176000.0 in Q3 2025, $93000.0 for Q2 2025, and -$714000.0 during Q1 2025.